000 | 01473 a2200421 4500 | ||
---|---|---|---|
005 | 20250516044304.0 | ||
264 | 0 | _c20111227 | |
008 | 201112s 0 0 eng d | ||
022 | _a1873-3476 | ||
024 | 7 |
_a10.1016/j.ijpharm.2011.06.024 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSantos, P | |
245 | 0 | 0 |
_aFormulation issues associated with transdermal fentanyl delivery. _h[electronic resource] |
260 |
_bInternational journal of pharmaceutics _cSep 2011 |
||
300 |
_a155-9 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article | ||
650 | 0 | 4 | _aAdministration, Cutaneous |
650 | 0 | 4 |
_aCellulose _xanalogs & derivatives |
650 | 0 | 4 |
_aChemistry, Pharmaceutical _xmethods |
650 | 0 | 4 | _aCrystallization |
650 | 0 | 4 | _aDiffusion Chambers, Culture |
650 | 0 | 4 |
_aExcipients _xchemistry |
650 | 0 | 4 |
_aFentanyl _xadministration & dosage |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aIn Vitro Techniques |
650 | 0 | 4 | _aMembranes, Artificial |
650 | 0 | 4 |
_aPermeability _xdrug effects |
650 | 0 | 4 |
_aPolymers _xchemistry |
650 | 0 | 4 |
_aPropylene Glycol _xchemistry |
650 | 0 | 4 |
_aSkin _xdrug effects |
650 | 0 | 4 |
_aSkin Absorption _xdrug effects |
650 | 0 | 4 | _aSolubility |
700 | 1 | _aWatkinson, A C | |
700 | 1 | _aHadgraft, J | |
700 | 1 | _aLane, M E | |
773 | 0 |
_tInternational journal of pharmaceutics _gvol. 416 _gno. 1 _gp. 155-9 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ijpharm.2011.06.024 _zAvailable from publisher's website |
999 |
_c20976744 _d20976744 |